ICAD INC (ICAD)

The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care

USA News Group  Commentary Issued on behalf of Avant Technologies Inc.   Vancouver, BC – December 17, 2024  – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a critical resource in healthcare, moving beyond its status as a novel concept. With over 800 FDA-cleared AI applications already in […]

SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

Reveals Higher Prevalence of Breast Arterial Calcifications (BAC) in Breast Cancer Patients, Suggesting Potential Need for Cardiovascular Assessment...

CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025...

iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025...

iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (

iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where...

iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024

NASHUA, N.H., Nov. 05, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions,...

iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven...

iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024

iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024

NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where...

ICAD Stock Earnings: icad Meets EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips icad (NASDAQ:ICAD) just reported results for the second quarter of 2024.icad re...

ICAD Stock Earnings: icad Meets EPS, Beats Revenue for Q2 2024

ICAD stock results show that icad met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

iCAD Reports Financial Results for Second Quarter Ended June 30, 2024

NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where...

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite Expansion...

iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

Newly Launched ProFound Cloud Delivers Radiologists Cost-Effective, Secure, and Scalable Access to iCAD’s Breast Health Suite of AI Solutions...

iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference

NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by...

3 Top Small-Cap Growth Opportunities in the AI Era

Small AI firms are benefiting from the pervasive, positive publicity about AI. Here are three small-cap growth stocks to buy.

ICAD Stock Earnings: icad Beats EPS, Beats Revenue for Q1 2024

ICAD stock results show that icad beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

iCAD Reports Financial Results for First Quarter Ended March 31, 2024

NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by...

UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

Call Time is 8:30 AM Eastern Time...

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions,...

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering...

iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast...

iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

Study confirms iCAD’s Breast Arterial Calcification AI Algorithm successfully detects calcification of breast vessels, an indicator of cardiovascular...

iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale

ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection...

Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market

These AI stocks will get big boosts from the proliferation of AI over the longer term, but the market is not giving them enough love.  

iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results

Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear...

The Hot List: 3 AI Stocks Worth Buying on Weakness

Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness. 

ICAD stock jumps 11% ahead of medical meeting presentations (NASDAQ:ICAD)

ICAD (ICAD) stock jumped 11% Wednesday after the company said it was making several presentations at the European Congress of Radiology annual meeting this week. Read more here.

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false...

iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)

Dr. Hricak offers extensive experience in radiology, real-world application of AI-enabled imaging solutions, research, and global healthcare perspectives...

iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical...

iCAD shares rally 15% amid GE Healthcare AI integration update (NASDAQ:ICAD)

iCAD (ICAD) shares rallied 15% on news that its AI-powered applications have been integrated into GE HealthCare's (GEHC) new MyBreastAI Suite for breast cancer detection.